324 related articles for article (PubMed ID: 18663783)
1. Taking the industry road.
Mejia R
Nature; 2008 Jun; 453(7198):1138-9. PubMed ID: 18663783
[No Abstract] [Full Text] [Related]
2. Is drug research trustworthy? The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it.
Seife C
Sci Am; 2012 Dec; 307(6):56-63. PubMed ID: 23230798
[No Abstract] [Full Text] [Related]
3. Conflicts of interest at the NIH: no easy solution.
Resnik DB
Hastings Cent Rep; 2005; 35(1):18-20. PubMed ID: 15799496
[No Abstract] [Full Text] [Related]
4. Funding, conflicts, and paradigms.
Gelenberg AJ
J Clin Psychiatry; 2005 May; 66(5):554. PubMed ID: 15889939
[No Abstract] [Full Text] [Related]
5. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
6. Trust, but verify.
Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
[No Abstract] [Full Text] [Related]
7. Medicine and the pharmaceutical industry.
Baxter P
Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
[No Abstract] [Full Text] [Related]
8. Ecology: caught between shores.
Hopkin M
Nature; 2006 Mar; 440(7081):144-5. PubMed ID: 16525438
[No Abstract] [Full Text] [Related]
9. Conflict of interest in the debate over calcium-channel antagonists.
Meltzer JI
N Engl J Med; 1998 Jun; 338(23):1696; author reply 1697-8. PubMed ID: 9616063
[No Abstract] [Full Text] [Related]
10. Profits, pressure, and perception: expensive research collides with medicine.
Hoey J
J Rheumatol; 2003 Aug; 30(8):1661-2. PubMed ID: 12913915
[No Abstract] [Full Text] [Related]
11. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.
Steinbrook R; Redberg RF
JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117
[No Abstract] [Full Text] [Related]
12. Conflict of interest in the debate over calcium-channel antagonists.
Opie L
N Engl J Med; 1998 Jun; 338(23):1696-7; author reply 1697-8. PubMed ID: 9616064
[No Abstract] [Full Text] [Related]
13. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
Avanzini G; Engel J
Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507
[No Abstract] [Full Text] [Related]
14. Potential conflicts cited in process for new drugs.
Bakalar N
N Y Times Web; 2005 Oct; ():F7. PubMed ID: 16276613
[No Abstract] [Full Text] [Related]
15. Independent medical research.
van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
[No Abstract] [Full Text] [Related]
16. Pharma buys a conscience.
Elliott C
Am Prospect; 2001 Sep 24-Oct 8; 12(17):16-20. PubMed ID: 16184653
[No Abstract] [Full Text] [Related]
17. Ethics. Senate inquiry on research conflicts shifts to grantees.
Kaiser J
Science; 2008 Jun; 320(5884):1708. PubMed ID: 18583586
[No Abstract] [Full Text] [Related]
18. How skeptical should we be about industry-sponsored studies?
Meador KJ
Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
[No Abstract] [Full Text] [Related]
19. Industry sponsored research.
Klotz LH
Can J Urol; 2004 Aug; 11(4):2312-3. PubMed ID: 15380051
[No Abstract] [Full Text] [Related]
20. Ghost story: at medical journals, writers paid by industry play big role.
Mathews AW
Wall St J (East Ed); 2005 Dec; ():A1, A8. PubMed ID: 16506304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
